Vivos Therapeutics (VVOS)
(Delayed Data from NSDQ)
$2.29 USD
+0.03 (1.33%)
Updated May 17, 2024 03:59 PM ET
After-Market: $2.25 -0.04 (-1.75%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Vivos Therapeutics, Inc. [VVOS]
Reports for Purchase
Showing records 1 - 20 ( 26 total )
Company: Vivos Therapeutics, Inc.
Industry: Medical - Drugs
Company: Vivos Therapeutics, Inc.
Industry: Medical - Drugs
Company: Vivos Therapeutics, Inc.
Industry: Medical - Drugs
Company: Vivos Therapeutics, Inc.
Industry: Medical - Drugs
Company: Vivos Therapeutics, Inc.
Industry: Medical - Drugs
Company: Vivos Therapeutics, Inc.
Industry: Medical - Drugs
Company: Vivos Therapeutics, Inc.
Industry: Medical - Drugs
Company: Vivos Therapeutics, Inc.
Industry: Medical - Drugs
Company: Vivos Therapeutics, Inc.
Industry: Medical - Drugs
Company: Vivos Therapeutics, Inc.
Industry: Medical - Drugs
Company: Vivos Therapeutics, Inc.
Industry: Medical - Drugs
3Q21 Recap - Positive Momentum Should Increase in 2022
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S